237 reports of this reaction
3.4% of all CARBIDOPA reports
#4 most reported adverse reaction
DEATH is the #4 most commonly reported adverse reaction for CARBIDOPA, manufactured by Bausch Health US, LLC. There are 237 FDA adverse event reports linking CARBIDOPA to DEATH. This represents approximately 3.4% of all 6,903 adverse event reports for this drug.
Patients taking CARBIDOPA who experience death should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DEATH is moderately reported among CARBIDOPA users, representing a notable but not dominant share of adverse events.
In addition to death, the following adverse reactions have been reported for CARBIDOPA:
The following drugs have also been linked to death in FDA adverse event reports:
DEATH has been reported as an adverse event in 237 FDA reports for CARBIDOPA. This does not prove causation, but indicates an association observed in post-market surveillance data.
DEATH accounts for approximately 3.4% of all adverse event reports for CARBIDOPA, making it a notable side effect.
If you experience death while taking CARBIDOPA, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.